相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Newborn Screening for Lysosomal Storage Disorders: Views of Genetic Healthcare Providers
Emily C. Lisi et al.
JOURNAL OF GENETIC COUNSELING (2016)
Is it Fabry disease?
Raphael Schiffmann et al.
GENETICS IN MEDICINE (2016)
Increased glycolipid storage produced by the inheritance of a complex intronic haplotype in the α-galactosidase A (GLA) gene
Javier Gervas-Arruga et al.
BMC GENETICS (2015)
Lysosomal Storage Disorder Screening Implementation: Findings from the First Six Months of Full Population Pilot Testing in Missouri
Patrick V. Hopkins et al.
JOURNAL OF PEDIATRICS (2015)
Pharmacological Chaperone Therapy: Preclinical Development, Clinical Translation, and Prospects for the Treatment of Lysosomal Storage Disorders
Giancarlo Parenti et al.
MOLECULAR THERAPY (2015)
Newborn screening for lysosomal storage disorders
Dietrich Matern et al.
SEMINARS IN PERINATOLOGY (2015)
Evaluation of the efficacy and safety of three dosing regimens of agalsidase alfa enzyme replacement therapy in adults with Fabry disease
Lubor Goláň et al.
Drug Design Development and Therapy (2015)
Newborn Screening for Lysosomal Storage Diseases
Michael H. Gelb et al.
CLINICAL CHEMISTRY (2015)
An intronic haplotype in α galactosidase A is associated with reduced mRNA expression in males with cryptogenic stroke
David A. Zeevi et al.
GENE (2014)
A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance
L. van der Tol et al.
JOURNAL OF MEDICAL GENETICS (2014)
Treatment of Lysosomal Storage Diseases: Recent Patents and Future Strategies
Saida Ortolano et al.
RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY (2014)
Newborn screening for Fabry disease in Japan: prevalence and genotypes of Fabry disease in a pilot study
Takahito Inoue et al.
JOURNAL OF HUMAN GENETICS (2013)
Identification of Infants at Risk for Developing Fabry, Pompe, or Mucopolysaccharidosis-I from Newborn Blood Spots by Tandem Mass Spectrometry
C. Ronald Scott et al.
JOURNAL OF PEDIATRICS (2013)
Newborn screening for lysosomal storage diseases: an ethical and policy analysis
Lainie Friedman Ross
JOURNAL OF INHERITED METABOLIC DISEASE (2012)
High Incidence of the Cardiac Variant of Fabry Disease Revealed by Newborn Screening in the Taiwan Chinese Population
Hsiang-Yu Lin et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2009)
High incidence of later-onset Fabry disease revealed by newborn screening
Marco Spada et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Direct multiplex assay of enzymes in dried blood spots by tandem mass spectrometry for the newborn screening of lysosomal storage disorders
Michael H. Gelb et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2006)
Fabry disease: Detection of undiagnosed hemodialysis patients and identification of a renal variant phenotype
S Nakao et al.
KIDNEY INTERNATIONAL (2003)
Fabry disease: D313Y is an alpha-galactosidase A sequence variant that causes pseudodeficient activity in plasma
R Froissart et al.
MOLECULAR GENETICS AND METABOLISM (2003)
Fabry disease: enzymatic diagnosis in dried blood spots on filter paper
NA Chamoles et al.
CLINICA CHIMICA ACTA (2001)